SPONSOR
Tel-Aviv Sourasky Medical Center
Total Trials
7
Recruiting
7
Phases
Phase 2, EARLY_Phase 1
Conditions studied: Refractory AnginaHealthyTNBC, Triple Negative Breast CancerEarly Breast CancerPost-Traumatic Stress Disorder, PTSDHormone Receptor Positive Breast CancerCancerEarly Detection of CancerST Segment Elevation Myocardial Infarction (STEMI)Cardiogenic Shock Post Myocardial Infarction
Tel-Aviv Sourasky Medical Center is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Refractory Angina, Healthy, TNBC, Triple Negative Breast Cancer, Early Breast Cancer.
The trial portfolio spans Phase 2, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Tel-Aviv Sourasky Medical Center
How many clinical trials has Tel-Aviv Sourasky Medical Center sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Tel-Aviv Sourasky Medical Center, of which 7 are actively recruiting participants. These trials cover conditions including Refractory Angina, Healthy, TNBC, Triple Negative Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Tel-Aviv Sourasky Medical Center research focus on?
Tel-Aviv Sourasky Medical Center clinical trials span Refractory Angina, Healthy, TNBC, Triple Negative Breast Cancer, Early Breast Cancer, Post-Traumatic Stress Disorder, PTSD, and additional conditions. The research pipeline includes Phase 2, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Tel-Aviv Sourasky Medical Center clinical trial?
To participate in a Tel-Aviv Sourasky Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Tel-Aviv Sourasky Medical Center trials with current recruitment status updated daily.
Clinical Trials by Tel-Aviv Sourasky Medical Center
NCT01566175
Recruiting
Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization
Refractory Angina
NCT05837884
Recruiting
Predicting Progression of Developing Myeloma in a High-Risk Screened Population and General Population
Healthy
NCT07327021 Phase 2
Recruiting
MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC
TNBC, Triple Negative Breast Cancer
NCT07737054 EARLY_Phase 1
Recruiting
Trauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for PTSD
Post-Traumatic Stress Disorder, PTSD
NCT07646171
Recruiting
EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+) Metastatic Breast Cancer (MBC)
Hormone Receptor Positive Breast Cancer
NCT06656728
Recruiting
CancerenD24 Screening as an Aid to the Clinician for the Diagnosis of Cancer
Cancer
NCT06967194
Recruiting
Early Beta Blocker Administration in STEMI Patients With SCAI B Status
ST Segment Elevation Myocardial Infarction (STEMI)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology